Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Adaptive Treatment Strategy for Adolescent Depression

Trial Profile

An Adaptive Treatment Strategy for Adolescent Depression

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 05 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms PTAD
  • Most Recent Events

    • 10 Jun 2016 Status changed from recruiting to completed.
    • 15 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Nov 2016 as per ClinicalTrials.gov record.
    • 07 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top